Synchrony Financial
1.47xPrice / book
Market cap
$24.72B
Tangible equity (USD)
—
Price / tangible book
—
Price / book
1.47x
Net income / ending equity
21.2%
Net income / ending assets
3.0%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: SYF stock price at discount vs ALNY $75.99 current versus $990.45 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ALNY's multiple
Implied fair value · at SYF's multiple
Snapshot Sep 11, 2026, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Multiple discount
Lower is better
Profitability lag
Asset efficiency lag
Lower is better
Statements
Reported bank earnings and balances, with each company’s reporting period shown.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
$24.72B
Tangible equity (USD)
—
Price / tangible book
—
Price / book
1.47x
Net income / ending equity
21.2%
Net income / ending assets
3.0%
Efficiency ratio
—
Price / book
Market cap
$33.28B
Tangible equity (USD)
—
Price / tangible book
—
Price / book
42.17x
Net income / ending equity
39.8%
Net income / ending assets
6.3%
Efficiency ratio
—
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Synchrony Financial · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
ALNYLAM PHARMACEUTICALS, INC. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CAPITAL ONE FINANCIAL CORP
SYF vs COF
American Express Company
SYF vs AXP
JPMorgan Chase & Co.
SYF vs JPM
Citigroup Inc.
SYF vs C
Moderna, Inc.
SYF vs MRNA
Sarepta Therapeutics, Inc.
SYF vs SRPT
VERTEX PHARMACEUTICALS INC / MA
SYF vs VRTX
BioNTech SE
SYF vs BNTX
ACADIA PHARMACEUTICALS INC
SYF vs ACAD
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.